Ingrid Delaet
Chief Regulatory Officer, Neurocrine Biosciences.
Companies
- Neurocrine BiosciencesChief Regulatory Officer Feb 15, 2023 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Neurocrine Biosciences NBIX18,289 shares2$2.5M at $136.95Sep 11, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 11, 2026Shares withheld for tax 2,419 shares at $156.22 of Neurocrine Biosciences2
- Sep 11, 2026Granted 4,483 shares of Neurocrine Biosciences2
- Jul 10, 2026Sold 4,367 shares at $181.02 of Neurocrine Biosciences3
- Jul 10, 2026Exercised options 4,367 shares at $106.02 of Neurocrine Biosciences3
- Jul 9, 2026Sold 8,433 shares at $178.72 of Neurocrine Biosciences4
- Jul 9, 2026Exercised options 8,433 shares at $103.52 of Neurocrine Biosciences4
- Jul 8, 2026Sold 2,737 shares at $178.54 of Neurocrine Biosciences4
- Jul 8, 2026Exercised options 2,737 shares at $103.52 of Neurocrine Biosciences4
- Jul 7, 2026Sold 3,401 shares at $178.57 of Neurocrine Biosciences4
- Jul 7, 2026Exercised options 3,401 shares at $103.52 of Neurocrine Biosciences4
- May 29, 2026Sold 2,261 shares at $156.71 of Neurocrine Biosciences5
- May 29, 2026Exercised options 2,261 shares at $79.02 of Neurocrine Biosciences5
- Feb 13, 2026Shares withheld for tax 10,755 shares at $124.12 of Neurocrine Biosciences6
- Feb 13, 2026Granted 19,935 shares of Neurocrine Biosciences6
- Feb 13, 2026Shares withheld for tax 734 shares at $124.12 of Neurocrine Biosciences6
- Feb 13, 2026Exercised options 1,359 shares of Neurocrine Biosciences6
- Feb 13, 2026Shares withheld for tax 756 shares at $124.12 of Neurocrine Biosciences6
- Feb 13, 2026Exercised options 1,401 shares of Neurocrine Biosciences6
- Feb 12, 2026Shares withheld for tax 881 shares at $123.10 of Neurocrine Biosciences6
- Feb 12, 2026Exercised options 1,600 shares of Neurocrine Biosciences6
- Jan 31, 2026Shares withheld for tax 475 shares at $136.06 of Neurocrine Biosciences7
- Jan 31, 2026Exercised options 801 shares of Neurocrine Biosciences7
- Jul 10, 2025Sold 457 shares at $135.00 of Neurocrine Biosciences8
- Jul 10, 2025Exercised options 457 shares at $79.02 of Neurocrine Biosciences8
- Feb 13, 2025Sold 755 shares at $116.72 of Neurocrine Biosciences9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Jul 13, 2026
- 4SEC EDGARForm 4 filed Jul 9, 2026
- 5SEC EDGARForm 4 filed Jun 2, 2026
- 6SEC EDGARForm 4 filed Feb 17, 2026
- 7SEC EDGARForm 4 filed Feb 3, 2026
- 8SEC EDGARForm 4 filed Jul 11, 2025
- 9SEC EDGARForm 4 filed Feb 14, 2025